LethalSpoon
Member
Last Activity: Yesterday, 9:04 AM
Joined: 16 Apr 2020
Location:
-
Out of 4 who tried, 3 used the peptide subcutaneous, and I don't think can work in that way
-
They will start trials with chronics this year,
"In January, we announced that we entered into a Memorandum of Understanding with Shirley Ryan AbilityLab with the intention of performing our first clinical trial in spinal cord injury patients. The single site clinical trial, which is expected... -
NervGen Pharma Receives Approval to Proceed to the Final Dose Cohort in Phase 1 Clinical Trial of NVG-291 and Reports Q1 2022 Results
https://www.newsfilecorp.com/release...1-2022-Results- Safety Review Committee approves proceeding to third and highest dose cohort in multiple ascending
Leave a comment:
-
Any news on the ARCEX? At this point we should have more info, taking into account they want to commercialize it in 2023.Leave a comment:
No activity results to display
Leave a comment: